The Bio Lp-1 whitepaper examines the urgent requirement for the rapid and accurate detection of Legionella to prevent the potential for widespread outbreaks of Legionnaires’ disease.

Such outbreaks will put additional pressure on already heavily burdened health care systems. The impact of the COVID-19 pandemic on Legionella trends is considered here.

We introduce our revolutionary multiplex assay for Legionella that has been developed to address this worrying potential trend. Bio Lp-1 can rapidly detect and quantify extremely low levels of Legionella in water samples enabling faster, better-informed decisions and assessment of actions required. Click here to download the whitepaper.

For further details, please use the 'Request Information' button provided below or visit BioProbe Diagnostics.